Is combination therapy with inhaled anticholinergics and beta2-adrenoceptor agonists justified for chronic obstructive pulmonary disease?
Chronic obstructive pulmonary disease (COPD) is a debilitating condition characterised by progressive, irreversible airflow limitation. The economic and social burden of the disease is enormous. The treatment of COPD is guided by the stage of the disease and is aimed primarily at control of symptoms. Bronchodilators are the cornerstone of pharmacological management of COPD. Short-acting bronchodilators (beta(2)-adrenoceptor agonists and anticholinergics) have been available for many years and have been extensively studied as individual agents and in combination. When administered in combination, short-acting bronchodilators provide superior bronchodilation compared with individual agents given alone. However, the improvement in bronchodilation does not translate into an improvement in quality-of-life (QOL) indices. More recently, long-acting beta(2)-adrenoceptor agonists (LABAs) and anticholinergics have been introduced, and current guidelines recommend regular use of these agents in COPD of Global initiative for chronic Obstructive Lung Disease (GOLD) stage II or more. Combining short-acting anticholinergics with LABAs for daily use has been evaluated, but this combination does not confer any advantage in terms of subjective improvement or prevention of exacerbations. Combining the long-acting anticholinergic tiotropium bromide with formoterol given once or twice daily improves airway obstruction and hyperinflation. However, the effects of combinations of long-acting bronchodilators on patients' symptom scores, QOL and exacerbations remain to be studied. Ultra-LABAs, which are in development, may enable use of a combination of long-acting bronchodilators in a single inhaler for once-daily use, thus simplifying the regimen. This article discusses the results of various clinical trials comparing the efficacy of bronchodilators given alone or in combination to patients with COPD, with emphasis on the effects of these agents on bronchodilation, symptomatic and objective improvements in QOL and prevention of exacerbations.
Reddy
Chakravarthy B
CB
Department of Medicine, Division of Respiratory, Critical Care and Occupational Pulmonary Medicine, University of Utah Health Sciences Center, Salt Lake City, Utah 84132-4701, USA. charkravarthy.reddy@hsc.utah.edu
Kanner
Richard E
RE
D000280:Administration, Inhalation; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage / Q000627:therapeutic use*; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D018680:Cholinergic Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D003692:Delayed-Action Preparations; D004359:Drug Therapy, Combination; D006801:Humans; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*; D011788:Quality of Life
D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D018680:Cholinergic Antagonists; D003692:Delayed-Action Preparations
Eur Respir J. 2005 Aug;26(2):214-22
16055868
Am J Med. 1996 Jan 29;100(1A):62S-69
8610720
JAMA. 1994 Nov 16;272(19):1497-505
7966841
Eur Respir J. 2002 Feb;19(2):209-16
11871363
Lancet. 1997 May 24;349(9064):1498-504
9167458
Respiration. 1986;50 Suppl 2:144-7
2951793
Am J Respir Crit Care Med. 2001 Sep 1;164(5):778-84
11549532
J Appl Physiol (1985). 1994 Jul;77(1):397-405
7525529
Thorax. 2003 May;58(5):399-404
12728159
Science. 1996 Nov 1;274(5288):740-3
8966556
Chest. 2000 Feb;117(2 Suppl):5S-9S
10673466
Chest. 2001 Jan;119(1):85-92
11157588
Chest. 1997 Dec;112(6):1514-21
9404747
Eur Respir J. 2001 May;17(5):946-53
11488331
Respiration. 1993;60(2):84-8
8341859
Am J Respir Crit Care Med. 1995 Sep;152(3):838-60
7663795
Postgrad Med J. 1984;60 Suppl 1:24-7
6233547
Am J Respir Crit Care Med. 2006 Mar 1;173(5):519-26
16322642
Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):822-6
9517597
N Engl J Med. 1986 Sep 18;315(12):735-9
2943994
Eur Respir J. 2004 Jun;23(6):832-40
15218994
Chest. 1995 Feb;107(2):401-5
7842768
Chest. 2006 Mar;129(3):509-17
16537846
Eur J Respir Dis. 1984 Aug;65(6):441-6
6236095
Am J Respir Crit Care Med. 2001 Sep 1;164(5):770-7
11549531
Br J Pharmacol. 1994 Feb;111(2):641-7
7911722
Proc Am Thorac Soc. 2005;2(4):282-9; discussion 290-1
16267349
Am Rev Respir Dis. 1983 Nov;128(5):833-8
6556892
Thorax. 2004 Jun;59(6):471-6
15170026
Thorax. 1996 Oct;51(10):1051-6
8984693
Pulm Pharmacol Ther. 2004;17(1):35-9
14643169
Am Rev Respir Dis. 1983 Jun;127(6):758-62
6305241
Am J Respir Crit Care Med. 2002 Aug 1;166(3):333-9
12153966
Clin Exp Immunol. 1996 Oct;106(1):97-102
8870705
Eur Respir J. 2002 Feb;19(2):217-24
11866001
Eur Respir J. 2006 Feb;27(2):397-412
16452599
Am J Respir Crit Care Med. 2001 Apr;163(5):1087-92
11316640
Chest. 2002 May;121(5 Suppl):121S-126S
12010839
Eur Respir J. 2002 Nov;20(5):1138-46
12449166
Am J Respir Crit Care Med. 1997 Jan;155(1):327-36
9001332
Am J Respir Crit Care Med. 2000 Jul;162(1):75-80
10903223
Int J Clin Pract. 1999 Apr-May;53(3):185-8
10665129
Am Rev Respir Dis. 1987 May;135(5):1069-74
3579005
Br J Dis Chest. 1981 Apr;75(2):190-6
7023528
Chest. 1999 May;115(5):1338-45
10334150
Chest. 2001 May;119(5):1347-56
11348938
Am J Respir Crit Care Med. 1997 Apr;155(4):1428-35
9105089
Respir Med. 1996 Sep;90(8):497-9
8869445
Thorax. 1996 Jan;51(1):48-53
8658369
Respir Med. 1999 Dec;93(12):909-11
10653054
Biochem Pharmacol. 1995 Jun 16;49(12 ):1809-19
7598743
Am J Med. 1996 Jan 29;100(1A):40S-48S
8610716
Eur Respir J. 2001 May;17(5):982-94
11488336
Chest. 1994 May;105(5):1411-9
8181328
Chest. 2002 Jul;122(1):47-55
12114338
Thorax. 1999 Dec;54(12):1083-6
10567627
Am J Respir Crit Care Med. 2001 Nov 15;164(10 Pt 2):S28-38
11734464
Respiration. 1986;50 Suppl 2:298-301
2951825
Chest. 1999 Mar;115(3):635-41
10084468
Chest. 1999 Apr;115(4):957-65
10208192
Eur Respir J. 2000 May;15(5):878-85
10853852
Am J Respir Crit Care Med. 1997 Mar;155(3):852-7
9117016
Respiration. 1998;65(5):354-62
9782217
Chest. 2002 May;121(5 Suppl):156S-159S
12010845
Thorax. 1982 Sep;37(9):667-70
6218647
Ann Intern Med. 2006 Jun 20;144(12):904-12
16754916
Chest. 1996 Jul;110(1):62-70
8681667
N Engl J Med. 1995 Aug 24;333(8):499-506
7623883
Arch Intern Med. 1999 Jan 25;159(2):156-60
9927098
Respir Med. 2004 Dec;98(12):1214-21
15588043
Am J Respir Crit Care Med. 1999 Aug;160(2):542-9
10430726
Am J Physiol. 1997 Apr;272(4 Pt 1):L580-7
9142928
J Gen Intern Med. 2006 Oct;21(10):1011-9
16970553
Eur Respir J. 1998 Jan;11(1):86-90
9543275
Thorax. 1997 Dec;52 Suppl 5:S1-28
9474238